Pharma · Private company
Roche Pharma AG
Track this companyFree. Adds Roche Pharma AG to your Dealase workspace and tells you when its record changes.
Clinical trials194 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials19
- HAIQU (Hospital AIr QUality)NA · NOT_YET_RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07670117 · fetched Nov 12, 2026
- PopSci CHW4CervixHealthNA · RECRUITING · started Oct 22, 2025ClinicalTrials.gov NCT07336134 · fetched Nov 12, 2026
- RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRCPHASE2 · TERMINATED · started Jun 29, 2023ClinicalTrials.gov NCT05733611 · fetched Nov 12, 2026
- Acceptability & Impact of a Diabetes Management Smartphone App (mySugr) for Spanish-literate Adults With Type 2 DiabetesNA · COMPLETED · started Apr 4, 2023ClinicalTrials.gov NCT05975242 · fetched Nov 12, 2026
- Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"NA · RECRUITING · started Dec 22, 2022ClinicalTrials.gov NCT05919342 · fetched Nov 12, 2026
- NT-I7 in Combination With Atezolizumab in Previously Untreated, PD-L1-expressing, Locally Advanced or Metastatic NSCLCPHASE2 · TERMINATED · started Nov 15, 2021ClinicalTrials.gov NCT04984811 · fetched Nov 12, 2026
- Fenofibrate for Prevention of DR WorseningPHASE3 · ACTIVE_NOT_RECRUITING · started Mar 5, 2021ClinicalTrials.gov NCT04661358 · fetched Nov 12, 2026
- Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell CarcinomaPHASE2 · UNKNOWN · started Dec 17, 2019ClinicalTrials.gov NCT03961698 · fetched Nov 12, 2026
- 5th Generation cTnT in ED ACSCOMPLETED · started Sep 24, 2018ClinicalTrials.gov NCT03590535 · fetched Nov 12, 2026
- Evaluation of the Roche Liat Flu/RSV Assay for Management of Influenza in the Emergency DepartmentNA · COMPLETED · started Mar 6, 2018ClinicalTrials.gov NCT02899065 · fetched Nov 12, 2026
- AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic StrokePHASE3 · TERMINATED · started Jan 19, 2018ClinicalTrials.gov NCT03192215 · fetched Nov 12, 2026
- Randomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead InPHASE1_PHASE2 · COMPLETED · started May 1, 2016ClinicalTrials.gov NCT02708680 · fetched Nov 12, 2026
- Rituximab Vasculitis Maintenance StudyPHASE3 · COMPLETED · started Apr 1, 2013ClinicalTrials.gov NCT01697267 · fetched Nov 12, 2026
- A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) in Participants With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN)PHASE3 · COMPLETED · started Apr 30, 2010ClinicalTrials.gov NCT01059630 · fetched Nov 12, 2026
- A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple SclerosisPHASE2 · COMPLETED · started Jul 17, 2008ClinicalTrials.gov NCT00676715 · fetched Nov 12, 2026
- Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon CancerPHASE2 · COMPLETED · started Feb 1, 2008ClinicalTrials.gov NCT00612586 · fetched Nov 12, 2026
- A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT)PHASE3 · TERMINATED · started May 15, 2007ClinicalTrials.gov NCT00476996 · fetched Nov 12, 2026
- A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Continuing Methotrexate Treatment (STAGE)PHASE3 · TERMINATED · started Dec 27, 2006ClinicalTrials.gov NCT00406419 · fetched Nov 12, 2026
- Comparison of Oral Valganciclovir and Placebo for the Prevention of Cytomegalovirus (CMV) After Lung TransplantationPHASE3 · COMPLETED · started Jul 1, 2003ClinicalTrials.gov NCT00227370 · fetched Nov 12, 2026